Max Chat
Company Analysis Medtronic
1. Summary
Advantages
- Dividends (3.16%) are higher than the sector average (1.28%).
- The stock's return over the last year (-4.48%) is higher than the sector average (-38.88%).
- The company's current efficiency (ROE=7.23%) is higher than the sector average (ROE=-83.32%)
Disadvantages
- Price (85.97 $) is higher than fair price (30.37 $)
- Current debt level 28.95% has increased over 5 years from 28.23%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Medtronic | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.4% | 0% | -0.3% |
| 90 days | 3.1% | -36.8% | 17.4% |
| 1 year | -4.5% | -38.9% | 11.1% |
MDT vs Sector: Medtronic has outperformed the "Healthcare" sector by 34.4% over the past year.
MDT vs Market: Medtronic has significantly underperformed the market by -15.6% over the past year.
Stable price: MDT is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: MDT with weekly volatility of -0.0861% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (85.97 $) is higher than the fair price (30.37 $).
Price is higher than fair: The current price (85.97 $) is 64.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (29.04) is lower than that of the sector as a whole (52.65).
P/E vs Market: The company's P/E (29.04) is lower than that of the market as a whole (61.84).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.12) is lower than that of the sector as a whole (10.86).
P/BV vs Market: The company's P/BV (2.12) is lower than that of the market as a whole (20.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.3) is lower than that of the sector as a whole (4.03).
P/S vs Market: The company's P/S indicator (3.3) is lower than that of the market as a whole (15.97).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (16.03) is lower than that of the sector as a whole (16.29).
EV/Ebitda vs Market: The company's EV/Ebitda (16.03) is lower than that of the market as a whole (18.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -4.65% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-4.65%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).
5.4. ROE
ROE vs Sector: The company's ROE (7.23%) is higher than that of the sector as a whole (-83.32%).
ROE vs Market: The company's ROE (7.23%) is lower than that of the market as a whole (42.62%).
5.5. ROA
ROA vs Sector: The company's ROA (4.06%) is lower than that of the sector as a whole (6.38%).
ROA vs Market: The company's ROA (4.06%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (9.79%) is lower than that of the sector as a whole (15.07%).
ROIC vs Market: The company's ROIC (9.79%) is higher than that of the market as a whole (9.15%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.16% is higher than the average for the sector '1.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.16% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 3.16% has been growing over the last 5 years. Growth over 11 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (99.73%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
